HYPD
HYPD
NASDAQ · Pharmaceuticals

Hyperion Defi Inc

$2.49
-0.07 (-2.73%)
As of Nov 7, 2:41 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +548.2% upside
Low Target $9.68
Average Target $16.14
High Target $20.98
Current Price $2.49
Current
$2.49
Target
$16.14
$9.68 $16.14 avg $20.98
Scenario Analysis
Bear Case
$9.68
288.8%
Low target
Base Case
$16.14
+548.2%
Avg target
Bull Case
$20.98
+742.6%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$6.48
-61.6% from high
52-Week Low
$2.34
+6.4% from low
Target vs 52W High
$16.14
+149.1% vs high
Next Earnings Report
Nov 12, 2026 · Before Market Open
4d
until earnings
EPS Est: $1.85
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%